Search Results - "Schizophrenia"

No association between the Ser9Gly polymorphism of the dopamine receptor D3 gene and schizophrenia: a meta-analysis of family-based association studies by Xiao-na Li, Ji-long Zheng, Xiao-han Wei, Bao-jie Wang, Jun Yao

Connect to this object online.

Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway by Yasushi Yabuki, Lei Wu, Kohji Fukunaga

Connect to this object online.

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study by Nestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, Jose Martinez-Raga, Carlos Parro-Torres, Julia Cambra Almerge, Lara Grau-López, Mario De Matteis, Francisco Arias

Connect to this object online.

Efficacy and safety of long-acting injectable oral antipsychotics in the treatment of patients with early-phase schizophrenia-spectrum disorders: a systematic review and meta-analysis by Giovanni Vita, Angelantonio Tavella, Giovanni Ostuzzi, Federico Tedeschi, Michele De Prisco, Rafael Segarra, Marco Solmi, Corrado Barbui, Christoph U. Correll

Connect to this object online.

<b>The meaning and implications of schizophrenia from the perspective of people who experience it</b> - doi: 10.4025/actascihealthsci.v35i1.11007 by Renata Marques Oliveira, Priscila Cristina Bim Rodrigues, Antonia Regina Ferreira Furegato, Antônio Carlos Siqueira Júnior

Connect to this object online.

Patient-controlled admissions to inpatient care: A twelve-month naturalistic study of patients with schizophrenia spectrum diagnoses and the effects on admissions to and days in inpatient care by Maria Skott, Natalie Durbeej, Maria Smitmanis-Lyle, Clara Hellner, Emelie Allenius, Sigrid Salomonsson, Tobias Lundgren, Nitya Jayaram-Lindström, Alexander Rozental

Connect to this object online.

Assessing the synergy between cholinomimetics and memantine as augmentation therapy in Cognitive Impairment in Schizophrenia. A virtual human patient trial using Quantitative Systems Pharmacology by Hugo eGeerts, Hugo eGeerts, Athan eSpiros, Patrick eRoberts, Patrick eRoberts

Connect to this object online.

Comparing Adherence to the Experience Sampling Method Among Patients With Schizophrenia Spectrum Disorder and Unaffected Individuals: Observational Study From the Multicentric DiAPAson Project by Cristina Zarbo, Manuel Zamparini, Olav Nielssen, Letizia Casiraghi, Matteo Rocchetti, Fabrizio Starace, Giovanni de Girolamo

Connect to this object online.

Clinical effectiveness of paliperidone palmitate 3‐monthly and 1‐monthly as monotherapy in patients with schizophrenia: A retrospective cohort study based on the Medicaid claims database by Chih‐Lin Chiang, Madoka Chinen, Mehmet Daskiran, Akihide Wakamatsu, Ibrahim Turkoz

Connect to this object online.

Omega-3 Fatty Acids in Health and Disease

Subjects: “…Schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

Reelin-Related Neurological Disorders and Animal Models by Laura Lossi

Subjects: “…Schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

Glutamate-Related Biomarkers for Neuropsychiatric Disorders

Subjects: “…schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

MR Spectroscopy in Neuropsychiatry by Alice Egerton

Subjects: “…Schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

Neural processing of emotion in multimodal settings by Klaus Mathiak

Subjects: “…Schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

Integrating Time & Number: From Neural Bases to Behavioral Processes through Development and Disease

Subjects: “…schizophrenia…”
DOAB: download the publication
DOAB: description of the publication

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy by Keqiang Wang, Meihong Xiu, Xiuru Su, Fengchun Wu, Xiangyang Zhang

Connect to this object online.

Measuring Users' Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study by Huerta-Ramos, Elena, Escobar-Villegas, Maria Soledad, Rubinstein, Katya, Unoka, Zsolt Szabolcs, Grasa, Eva, Hospedales, Margarita, Jääskeläinen, Erika, Rubio-Abadal, Elena, Caspi, Asaf, Bitter, István, Berdun, Jesus, Seppälä, Jussi, Ochoa, Susana, Fazekas, Kata, Corripio, Iluminada, Usall, Judith

Connect to this object online.

Experiencing feelings and weaknesses of care in schizophrenia: family caregivers vision Vivenciando sentimentos e fragilidades do cuidar em esquizofrenia: visão de familiares cuidadores by Israel Coutinho Sampaio Lima, Sérgio Beltrão de Andrade Lima

Connect to this object online.

Association between polymorphisms in the GRIN1 gene 5' regulatory region and schizophrenia in a northern Han Chinese population and haplotype effects on protein expression in vitro by Yong-ping Liu, Mei Ding, Xi-cen Zhang, Yi Liu, Jin-feng Xuan, Jia-xin Xing, Xi Xia, Jun Yao, Bao-jie Wang

Connect to this object online.

A multicenter, single‐arm, open‐label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder by Kazuyuki Nakagome, Hisateru Tachimori, Shiro Endo, Ken Murakami, Takaharu Azekawa, Seiji Hongo, Kazunari Niidome, Yoshitsugu Kojima, Sakiko Yamada, Hideki Oi, Tomiki Sumiyoshi

Connect to this object online.